APA
Mignogna M. D., Leuci S., Fedele S., Ruoppo E., Adamo D., Russo G. & Pagliuca R. (20090126). Adjuvant high-dose intravenous immunoglobulin therapy can be easily and safely introduced as an alternative treatment in patients with severe pemphigus vulgaris: a retrospective preliminary study. : American journal of clinical dermatology.
Chicago
Mignogna Michele Davide, Leuci Stefania, Fedele Stefano, Ruoppo Elvira, Adamo Daniela, Russo Giuseppina and Pagliuca Raffaella. 20090126. Adjuvant high-dose intravenous immunoglobulin therapy can be easily and safely introduced as an alternative treatment in patients with severe pemphigus vulgaris: a retrospective preliminary study. : American journal of clinical dermatology.
Harvard
Mignogna M. D., Leuci S., Fedele S., Ruoppo E., Adamo D., Russo G. and Pagliuca R. (20090126). Adjuvant high-dose intravenous immunoglobulin therapy can be easily and safely introduced as an alternative treatment in patients with severe pemphigus vulgaris: a retrospective preliminary study. : American journal of clinical dermatology.
MLA
Mignogna Michele Davide, Leuci Stefania, Fedele Stefano, Ruoppo Elvira, Adamo Daniela, Russo Giuseppina and Pagliuca Raffaella. Adjuvant high-dose intravenous immunoglobulin therapy can be easily and safely introduced as an alternative treatment in patients with severe pemphigus vulgaris: a retrospective preliminary study. : American journal of clinical dermatology. 20090126.